[
  {
    "ts": "2026-02-23T13:00:00+00:00",
    "headline": "Telescope Innovations Installs Second Self-Driving Lab at Pfizer",
    "summary": "Installation of second Physical AI platform positions Telescope Innovations to successfully address the rapidly expanding SDL marketVancouver, British Columbia--(Newsfile Corp. - February 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (\"Telescope\" or the \"Company\"), a developer of enabling technologies and services for the global pharmaceutical and chemical industries, is pleased to announce the installation of its second Self-Driving Laboratory (\"SDL\") at Pfizer,.",
    "url": "https://finance.yahoo.com/news/telescope-innovations-installs-second-self-130000109.html",
    "source": "TMX Newsfile",
    "provider": "yfinance",
    "raw": {
      "id": "d8e0c6c9-691a-30d2-bbf5-5c5aa37a9c9d",
      "content": {
        "id": "d8e0c6c9-691a-30d2-bbf5-5c5aa37a9c9d",
        "contentType": "STORY",
        "title": "Telescope Innovations Installs Second Self-Driving Lab at Pfizer",
        "description": "",
        "summary": "Installation of second Physical AI platform positions Telescope Innovations to successfully address the rapidly expanding SDL marketVancouver, British Columbia--(Newsfile Corp. - February 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (\"Telescope\" or the \"Company\"), a developer of enabling technologies and services for the global pharmaceutical and chemical industries, is pleased to announce the installation of its second Self-Driving Laboratory (\"SDL\") at Pfizer,.",
        "pubDate": "2026-02-23T13:00:00Z",
        "displayTime": "2026-02-23T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/newsfile_64/41eaf4a8c8b64f858b086bafb581d911",
          "originalWidth": 400,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kEhY_X5lhb_5RxNkEv1WUA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/41eaf4a8c8b64f858b086bafb581d911.cf.webp",
              "width": 400,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ROsnsPZIqq.pEWS2CgB5mA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/newsfile_64/41eaf4a8c8b64f858b086bafb581d911.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "TMX Newsfile",
          "url": "https://www.newsfilecorp.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/telescope-innovations-installs-second-self-130000109.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/telescope-innovations-installs-second-self-130000109.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TELI.CN"
            },
            {
              "symbol": "J4U.F"
            },
            {
              "symbol": "TELIF"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-23T14:00:00+00:00",
    "headline": "Neutrolis Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors as Executive Director",
    "summary": "Dr. Dolsten, former Chief Scientific Officer and President of Worldwide Research, Development, and Medical at Pfizer, brings leadership experience spanning approximately 50 regulatory approvals and over $100 billion in biopharma transactionsNeutrolis expects to initiate Phase 1b studies in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in mid-2026 CAMBRIDGE, Ma., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Neutrolis, a clinical-stage biotechnology company pioneering a new class of rapid-",
    "url": "https://finance.yahoo.com/news/neutrolis-appoints-mikael-dolsten-m-140000647.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "89b4d2f5-1a27-31ff-ba39-de824d4a38d4",
      "content": {
        "id": "89b4d2f5-1a27-31ff-ba39-de824d4a38d4",
        "contentType": "STORY",
        "title": "Neutrolis Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors as Executive Director",
        "description": "",
        "summary": "Dr. Dolsten, former Chief Scientific Officer and President of Worldwide Research, Development, and Medical at Pfizer, brings leadership experience spanning approximately 50 regulatory approvals and over $100 billion in biopharma transactionsNeutrolis expects to initiate Phase 1b studies in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in mid-2026 CAMBRIDGE, Ma., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Neutrolis, a clinical-stage biotechnology company pioneering a new class of rapid-",
        "pubDate": "2026-02-23T14:00:00Z",
        "displayTime": "2026-02-23T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/5f94c582e3049f1a60e3fe54a40e8e1f",
          "originalWidth": 1167,
          "originalHeight": 709,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N_tgV5DZcKQaeAmZ.E_lSg--~B/aD03MDk7dz0xMTY3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/5f94c582e3049f1a60e3fe54a40e8e1f.cf.webp",
              "width": 1167,
              "height": 709,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uNdYPrVTiJgOtNRPKURxwA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5f94c582e3049f1a60e3fe54a40e8e1f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/neutrolis-appoints-mikael-dolsten-m-140000647.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/neutrolis-appoints-mikael-dolsten-m-140000647.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]